Obestatin Enhances In Vitro Generation of Pancreatic Islets through Regulation of Developmental Pathways
Authors:
Open Access
- 31 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5) , e64374
Abstract
Availability of large amounts of in vitro generated β-cells may support replacement therapy in diabetes. However, methods to obtain β-cells from stem/progenitor cells are limited by inefficient endocrine differentiation. We have recently shown that the ghrelin gene product obestatin displays beneficial effects on pancreatic β-cell survival and function. Obestatin prevents β-cell apoptosis, preserves β-cell mass and stimulates insulin secretion in vitro and in vivo, in both normal and diabetic conditions. In the present study, we investigated whether obestatin may promote in vitro β-cell generation from mouse pancreatic islet-derived precursor cells. Treatment of cultured islets of Langerhans with obestatin (i) enriched cells expressing the mesenchymal/neuronal marker nestin, which is associated with pancreatic precursors; (ii) increased cell survival and reduced apoptosis during precursor selection; (iii) promoted the generation of islet-like cell clusters (ICCs) with increased insulin gene expression and C-peptide secretion. Furthermore, obestatin modulated the expression of fibroblast growth factor receptors (FGFRs), Notch receptors and neurogenin 3 (Ngn3) during islet-derived precursor cell selection and endocrine differentiation. These results indicate that obestatin improves the generation of functional β-cells/ICCs in vitro, suggesting implications for cell-based replacement therapy in diabetes. Moreover, obestatin may play a role in regulating pathways involved in pancreas development and regeneration.Keywords
This publication has 50 references indexed in Scilit:
- Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cellsProceedings of the National Academy of Sciences, 2010
- Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn ratsJournal of Molecular Endocrinology, 2010
- Conversion of adult pancreatic α-cells to β-cells after extreme β-cell lossNature, 2010
- Stem cell therapy for type 1 diabetes mellitusNature Reviews Endocrinology, 2010
- Artifactual Insulin Release From Differentiated Embryonic Stem CellsDiabetes, 2004
- Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregatesProceedings of the National Academy of Sciences, 2003
- The ghrelin cell: a novel developmentally regulated islet cell in the human pancreasRegulatory Peptides, 2002
- Role for FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell proliferationProceedings of the National Academy of Sciences, 2002
- Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic IsletsScience, 2001
- Proinsulin and C-Peptide in BloodDiabetes, 1972